Featured News
495NewsSchneider Electric makes steady progress toward 2025 sustainability targets
HONG KONG SAR – Media OutReach – 12 August 2022 – Schneider Electric, the leader in the digital transformation of energy management...
- 553Wire Stories
MUFG Bank, Ltd. announces Risk-Adjusted Capital Ratio Based on the Basel 3 Standards for the First Quarter Ended June 30, 2022
TOKYO–(BUSINESS WIRE)–MUFG hereby announces the risk-adjusted capital ratio based on the Basel 3 standards for the first quarter ended June 30, 2022...
- 550News
Virtuos Bolsters Southeast Asian Presence With Launch of Game Development Studio in Kuala Lumpur
Founded by local games industry pioneers, Virtuos Kuala Lumpur supports the growth of Malaysia as a regional game development hub through talent...
- 521News
Appier continues its strong growth momentum and raises full-year guidance second quarter in a row
Significant growth, profitability and international expansion to underscore Appier’s focus in second half of 2022 Highlights and achievements for the second quarter...
- 523News
HyD holds “Building and Maintaining Highway Infrastructure through Innovation in Highways Department” exhibition in celebration of HKSAR 25th anniversary
HONG KONG SAR – Media OutReach – 12 August 2022 – To celebrate the 25th anniversary of the establishment of the Hong...
- 503Wire Stories
InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that the Center...
- 656Wire Stories
Eurofins Strengthens Its Comprehensive Food Testing Offering in Japan Through the Acquisition of QSAI Analysis and Research Center Co.,Ltd.
LUXEMBOURG–(BUSINESS WIRE)–Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in food testing and a global scientific leader in bioanalytical testing, announces...
- 550Wire Stories
Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku
TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity, its immunological...
- 479Wire Stories
Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku
TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data from human clinical trials concerning the effects of Agaricus blazei mushroom, KA21...
- 596Wire Stories
Survey of degree of satisfaction with Agaricus blazei mushroom KA21 for promoting the health of senior dogs and cats among veterinarians and pet owners, Toei Shinyaku
Improvement of the appetite, coat & amount of fur, and amount of exercise among senior dogs and cats TOKYO–(BUSINESS WIRE)–A survey was...
- 555Wire Stories
Toei Shinyaku Acquires Patent for Measurement Method of Beta-glucan, a Main Ingredient of Agaricus blazei mushroom
TOKYO–(BUSINESS WIRE)–Through its research on Agaricus blazei, KA21 strain, Toei Shinyaku has established a measurement method for beta-glucan, one of the main...
